RXRX — RECURSION PHARMACEUTICALS IN
As of Q2 2026, 37 SEC-registered investment managers reported holding RXRX (RECURSION PHARMACEUTICALS IN) in their latest 13F filings, with a combined reported value of $674.71M across 184.53M shares. That is +12.6% by share count (+20.71M shares) versus the previous quarter, while reported value moved +34.6%. Ownership is concentrated: the five largest holders account for 75.0% of reported value and the top ten for 88.3%.
Compared with the prior quarter, 3 opened new positions, 25 added to existing stakes, 8 trimmed, 3 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
RXRX is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q4 2025 | 47.19M | $193.00M | 0.00% | Add |
| BlackRock Inc history | Q2 2026 | 50.30M | $184.62M | 0.00% | Add |
| ARK Invest history | Q2 2026 | 41.34M | $151.71M | 0.98% | Add |
| Baillie Gifford & Co history | Q2 2026 | 23.49M | $86.20M | 0.08% | Reduce |
| Geode Capital Management history | Q2 2026 | 13.82M | $50.72M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 8.95M | $32.84M | 0.00% | Add |
| Norges Bank Investment Management history | Q2 2026 | 6.83M | $25.08M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 4.76M | $17.46M | 0.00% | Add |
| Marshall Wace history | Q2 2026 | 4.71M | $17.30M | 0.01% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 4.14M | $15.19M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 3.92M | $14.38M | 0.00% | Reduce |
| Alkeon Capital Management history | Q3 2021 | 548.46K | $12.62M | 0.02% | New |
| Two Sigma Investments history | Q2 2026 | 3.35M | $12.31M | 0.01% | Reduce |
| MFS Investment Management history | Q3 2022 | 950.59K | $10.11M | 0.00% | Reduce |
| Morgan Stanley history | Q2 2026 | 2.74M | $10.07M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 2.60M | $9.53M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 2.54M | $9.32M | 0.00% | Add |
| Renaissance Technologies history | Q1 2026 | 2.40M | $7.37M | 0.01% | New |
| Baron Funds history | Q4 2021 | 408.56K | $7.00M | 0.01% | Reduce |
| Millennium Management history | Q2 2026 | 1.83M | $6.73M | 0.00% | Reduce |
New Positions (Q2 2026)
- JPMorgan Chase & Co 1.15M sh · $4.32M
- Bridgewater Associates 37.67K sh · $138.24K
- CPP Investments 31.30K sh · $114.87K
Fully Exited (vs previous quarter)
- Renaissance Technologies sold 2.40M sh · $7.37M
- Janus Henderson Group sold 220.31K sh · $675.25K
- Point72 Asset Management sold 46.30K sh · $142.14K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | — | — | — | — | — | — | — | — | — | — | — | — | 20.74M | 23.44M | 23.51M | 28.37M | 31.74M | 38.87M | 43.19M | 50.30M |
| ARK Invest | 2.59M | 2.23M | 2.83M | 2.73M | 3.36M | 3.10M | 3.58M | 4.74M | 6.88M | 20.65M | 24.59M | 28.14M | 32.77M | 32.35M | 34.82M | 32.99M | 33.55M | 37.32M | 40.21M | 41.34M |
| Baillie Gifford & Co | 22.06M | 22.12M | 21.98M | 21.61M | 21.59M | 24.82M | 25.14M | 25.10M | 24.55M | 24.18M | 24.07M | 26.59M | 25.24M | 24.86M | 24.39M | 24.17M | 23.98M | 23.77M | 23.68M | 23.49M |
| Geode Capital Management | 562.33K | 1.29M | 1.29M | 1.51M | 2.33M | 2.61M | 2.74M | 2.81M | 3.14M | 3.33M | 3.45M | 4.78M | 5.43M | 6.09M | 6.44M | 7.78M | 9.62M | 10.93M | 12.28M | 13.82M |
| UBS Group AG | 71.14K | 259.22K | 6.93K | 4.99K | 18.46K | 361.89K | 168.94K | 168.72K | 342.68K | 691.91K | 672.43K | 1.65M | 799.86K | 3.00M | 5.57M | 4.63M | 3.94M | 3.74M | 5.14M | 8.95M |
| Norges Bank Investment Management | — | — | — | — | — | 4.37M | — | — | — | 3.53M | — | 1.95M | — | 3.47M | — | 3.17M | — | 5.74M | — | 6.83M |
| Northern Trust Corp | 250.67K | 885.96K | 859.54K | 981.28K | 1.13M | 1.16M | 1.16M | 1.25M | 1.31M | 1.30M | 1.29M | 1.31M | 2.02M | 2.39M | 2.40M | 2.91M | 3.34M | 3.44M | 3.97M | 4.76M |
| Marshall Wace | — | — | — | 106.79K | — | — | 514.14K | — | — | — | 391.52K | — | — | — | 333.61K | 86.31K | 78.26K | 226.61K | 2.88M | 4.71M |
| Charles Schwab Investment Management | 182.77K | 377.24K | 373.16K | 428.34K | 904.50K | 984.68K | 983.94K | 1.00M | 1.16M | 1.19M | 1.21M | 1.65M | 1.94M | 2.27M | 2.28M | 2.59M | 3.45M | 3.99M | 3.81M | 4.14M |
| Goldman Sachs Group | 18.67K | 123.59K | 209.41K | 196.07K | 358.07K | 583.00K | 535.13K | 577.45K | 664.77K | 1.19M | 897.02K | 1.07M | 1.63M | 2.15M | 1.50M | 1.13M | 1.26M | 2.20M | 6.07M | 3.92M |
| Two Sigma Investments | — | — | 200.13K | — | — | 73.10K | 208.14K | — | 392.32K | 532.64K | 896.48K | 1.43M | 1.60M | 1.66M | 1.15M | 1.17M | 2.45M | 3.08M | 4.07M | 3.35M |
| Morgan Stanley | 9.70K | 115.50K | 140.60K | 221.70K | 275.94K | 333.17K | 259.37K | 390.23K | 806.62K | 2.58M | 1.96M | 1.77M | 1.88M | 2.86M | 5.01M | 5.69M | 7.29M | 5.66M | 2.19M | 2.74M |
| Bank of America Corp | 26.51K | 171.18K | 83.68K | 106.22K | 198.87K | 421.86K | 557.01K | 230.72K | 899.36K | 785.88K | 1.70M | 1.84M | 1.30M | 1.24M | 1.49M | 2.30M | 1.96M | 2.11M | 2.50M | 2.60M |
| Citadel Advisors | 37.80K | 217.01K | 931.07K | 351.37K | 532.37K | 791.55K | 650.72K | 770.76K | 465.29K | 249.19K | 798.87K | 1.55M | 1.09M | 4.56M | 4.39M | 3.73M | 4.38M | 8.17M | 2.43M | 2.54M |
| Millennium Management | — | 93.83K | 495.15K | 383.17K | 239.40K | 695.37K | 646.61K | — | 658.36K | — | 52.38K | 100.00K | 70.48K | 28.31K | 502.11K | 739.41K | — | 1.50M | 2.61M | 1.83M |
| BNY Mellon | 104.03K | 367.41K | 373.70K | 399.35K | 503.94K | 505.45K | 529.16K | 596.69K | 634.01K | 833.27K | 881.81K | 1.06M | 926.12K | 850.64K | 863.22K | 1.08M | 1.37M | 1.13M | 1.46M | 1.64M |
| JPMorgan Chase & Co | 31.60K | 156.43K | 127.04K | 169.35K | 181.14K | 173.34K | 204.82K | 374.86K | 954.90K | 380.81K | 1.23M | 1.11M | 1.18M | 1.06M | 818.32K | 399.50K | 419.62K | 1.28M | — | 1.15M |
| Citigroup Inc | 45.29K | 244.36K | 14.90K | 12.30K | 161.56K | 232.83K | 688.23K | 177.34K | 470.51K | 404.85K | 863.89K | 103.61K | 190.75K | 545.19K | 659.45K | 214.75K | 66.40K | 230.29K | 182.61K | 954.40K |
| Invesco Ltd | — | 43.47K | 44.63K | 44.28K | 44.95K | 44.62K | 119.22K | 106.51K | 107.09K | 120.89K | 98.56K | 108.27K | 115.55K | 178.62K | 202.53K | 319.11K | 418.17K | 526.14K | 691.15K | 795.70K |
| Lazard Asset Management | — | 143.38K | 188.92K | 289.61K | 304.21K | 163.91K | 345.54K | 345.12K | 335.02K | 371.70K | 280.67K | 524.16K | 642.31K | 555.85K | 506.14K | 404.36K | 495.16K | 420.01K | 400.76K | 692.38K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details